I was taught to be suspicious of atheists or non-religious people. So I was humbled to find that as a Christian leader in ...

Cebranopadol, a dual-NMR agonist, reached the primary endpoint in a Phase III trial and matched placebo for safety, a ...

Christopher Sayed, MD, discusses how hidradenitis suppurativa typically presents and looks forward, following the November approval of bimekizumab.

Because a new toilet was being installed in my bathroom already, it seemed like the perfect time to elevate the space with a ...

The study casts a spotlight on a critical public health issue: the uneven burden of contaminated drinking water on minority ...

As winter's icy grip tightens, the risk of slip-and-fall injuries increases dramatically. You may navigate treacherous ...